Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
1.240
-0.020 (-1.59%)
Nov 21, 2024, 4:00 PM EST - Market closed
Century Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 105 | 199 | 303 | 867 | - | - |
| Market Cap Growth | 21.19% | -34.34% | -65.09% | - | - | - |
| Enterprise Value | -36 | 77 | -6 | 597 | - | - |
| Last Close Price | 1.26 | 3.32 | 5.13 | 15.86 | - | - |
| PS Ratio | 33.94 | 88.88 | 58.19 | - | - | - |
| PB Ratio | 0.55 | 1.08 | 1.00 | 2.19 | - | - |
| P/TBV Ratio | 0.92 | 1.08 | 1.00 | 2.19 | - | - |
| P/OCF Ratio | - | - | 21.53 | - | - | - |
| EV/Sales Ratio | 1.80 | 34.33 | - | - | - | - |
| Debt / Equity Ratio | 0.28 | 0.26 | 0.16 | 0.06 | 0.29 | - |
| Asset Turnover | 0.01 | 0.01 | 0.01 | - | - | - |
| Quick Ratio | 10.06 | 9.80 | 10.61 | 14.25 | 6.33 | 27.28 |
| Current Ratio | 10.39 | 9.92 | 10.72 | 14.57 | 6.51 | 28.10 |
| Return on Equity (ROE) | -62.61% | -56.07% | -37.46% | -40.81% | -66.45% | - |
| Return on Assets (ROA) | -20.90% | -18.47% | -16.75% | -21.80% | -31.10% | - |
| Return on Capital (ROIC) | -31.78% | -26.74% | -20.01% | -22.97% | -33.63% | - |
| Earnings Yield | -121.24% | -68.80% | -43.28% | -11.06% | - | - |
| FCF Yield | -105.59% | -51.39% | -5.47% | -15.46% | - | - |
| Buyback Yield / Dilution | -22.76% | -2.70% | -78.30% | -332.95% | -10.43% | - |
| Total Shareholder Return | -22.76% | -2.70% | -78.30% | -332.95% | -10.43% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.